Bora Pharmaceuticals Co., Ltd. (TPE:6472)

Market Cap	56.62B -39.5%
Revenue (ttm)	21.10B +36.0%
Net Income	3.08B -24.4%
EPS	24.04 -22.3%
Shares Out	124.02M
PE Ratio	14.00
Forward PE	10.86
Dividend	11.67 (2.56%)
Ex-Dividend Date	Jun 20, 2025

Volume	1,276,797
Average Volume	1,124,357
Open	453.00
Previous Close	462.00
Day's Range	441.00 - 458.00
52-Week Range	444.00 - 795.00
Beta	0.72
RSI	37.71
Earnings Date	Mar 11, 2026

About Bora Pharmaceuticals

Bora Pharmaceuticals Co., Ltd. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services and technical services for the development of pharmaceutical products. In addition, it provides Western pharmaceuticals, including central nervous system medications, antibioti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2007
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6472

Financial Performance

In 2024, Bora Pharmaceuticals's revenue was 19.25 billion, an increase of 35.53% compared to the previous year's 14.20 billion. Earnings were 3.94 billion, an increase of 29.99%.